Differential role of naïve and memory CD4+ T-cell subsets in primary alloresponses

American Journal of Transplantation

Volumn 10, Issue 8, 2010, Pages 1749-1759

  Golshayan, D ^a   Wyss, J C ^a   Buckland, M ^b   Hernandez Fuentes, M ^b   Lechler, R I ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Allorecognition; indirect pathway; memory T cells; naive T cells; transplantation

Indexed keywords

ALLOANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; GRAFT REJECTION; HOMEOSTASIS; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTOPENIA; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN TRANSPLANTATION;

ADOPTIVE TRANSFER; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; FORKHEAD TRANSCRIPTION FACTORS; GRAFT REJECTION; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; ISOANTIGENS; MICE; SKIN TRANSPLANTATION; T-LYMPHOCYTE SUBSETS;

EID: 77954922205     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2010.03180.x     Document Type: Article

References (50)

1. Rogers NJ, Lechler RI. Allorecognition. Am J Transplant 2000 2 : 97 102.
2. + T cell-mediated cardiac allograft rejection requires donor but not host MHC class II. J Clin Invest 2000 106 : 1003 1010.
3. + T cells or B cells. J Immunol 1998 161 : 1868 1874.
4. Lee RS, Grusby MJ, Glimcher LH, Winn HJ, Auchincloss H Jr. Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo. J Exp Med 1994 179 : 865 872.
5. Steele JR, Laufer TM, Smiley ST et al. Two levels of help for B cell alloantibody production. J Exp Med 1996 183 : 699 703.
6. + cells are essential for allorejection. J Exp Med 1996 184 : 2013.
7. -/- mice are sufficient to mediate the rejection of MHC class II or class I disparate skin grafts. J Immunol 1996 156 : 4114.
8. Sprent J, Surh CD. Generation and maintenance of memory T cells. Curr Opin Immunol 2002 13 : 248 254.
9. Berard M, Tough DF. Qualitative differences between naïve and memory T cells. Immunology 2002 106 : 127 138.
10. + T cells. J Immunol 2000 164 : 265 272.
11. Rogers PR, Dubey C, Swain SL. Qualitative changes accompany memory T cell generation: Faster, more effective responses at lower doses of antigen. J Immunol 2000 164 : 2338 2346.
12. Grusby MJ, Johnson RS, Papaioannou VE, Glimcher LH. Depletion of CD4+ T-Cells in Major Histocompatibility Complex Class II - Deficient Mice. Science 1991 253 : 1417 1420.
13. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999 401 : 708 712.
14. Lanzavecchia A, Sallusto F. Dynamics of T lymphocyte responses: Intermediates, effectors, and memory cells. Science 2000 290 : 92 97.
15. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003 299 : 1057 1061.
16. Bell EB, Sparshott SM. Interconversion of CD45R subsets of CD4 T cells in vivo. Nature 1990 348 : 163 166.
17. Sprent J, Zhang X, Sun S, Tough D. T-cell proliferation in vivo and the role of cytokines. Philos Trans R Soc Lond B Biol Sci 2000 355 : 317 322.
18. Sener A, Tang AL, Farber DL. Memory T-cell predominance following T-cell depletional therapy derives from homeostatic expansion of naive T cells. Am J Transplant 2009 9 : 2615 2623.
19. low CD4 T cells are important for the balance between protective and pathogenic cell-mediated immunity. J Exp Med 1994 179 : 589 600.
20. Hara M, Kingsley CI, Niimi M et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 2001 166 : 3789 3796.
21. Luke PPW, Deng JP, Lian D et al. Prolongation of allograft survival by administration of anti-CD45RB monoclonal antibody is due to alteration of CD45RBhi: CD45RBlo T-cell proportions. Am J Transplant 2006 6 : 2023 2034.
22. Luke PPW, O'Brien CA, Jevnikar AM, Zhong R. Anti-CD45RB monoclonal antibody-mediated transplantation tolerance. Curr Mol Med 2001 1 : 533 543.
23. Lazarovits AI, Poppema S, Zhang Z et al. Prevention and reversal of renal allograft rejection by antibody against CD45RB. Nature 1996 380 : 717 720.
24. Anderson BE, McNiff J, Yan J et al. Memory CD4+ T cells do not induce graft-versus-host disease. J Clin Invest 2003 112 : 101 108.
25. Xystrakis E, Bernard I, Dejean AS, Druet P, Saoudi A. Alloreactive CD4 T lymphocytes responsible for acute and chronic graft-versus-host disease are contained within the CD45RChigh but not the CD45RClow subset. Eur J Immunol 2004 34 : 408 417.
26. Foster AE, Marangolo M, Sartor MM et al. Human CD62L- memory T cells are less responsive to alloantigen stimulation than CD62L+ naive T cells: Potential for adoptive immunotherapy and allodepletion. Blood 2004 104 : 2403 2409.
27. Anderson BE, Taylor PA, McNiff JM et al. Effects of donor T-cell trafficking and priming site on graft-versus-host disease induction by naïve and memory phenotype CD4 T cells. Blood 2008 111 : 5242 5251.
28. Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004 22 : 531 562.
29. Graca L, Thompson S, Lin CY, Adams E, Cobbold SP, Waldmann H. Both CD4(+)CD25(+) and CD4(+)CD25(-) regulatory cells mediate dominant transplantation tolerance. J Immunol 2002 168 : 5558 5565.
30. Lehmann J, Huehn J, de la Rosa M et al. Expression of the integrin alpha Ebeta 7 identifies unique subsets of CD25+ as well as CD25- regulatory T cells. Proc Natl Acad Sci USA 2002 99 : 13031 13036.
31. Bottomly K, Luqman M, Greenbaum L et al. A monoclonal antibody to murine CD45R distinguishes CD4 T cell populations that produce different cytokines. Eur J Immunol 1989 19 : 617 623.
32. Lee WT, Yin XM, Vitetta ES. Functional and ontogenetic analysis of murine CD45Rhi and CD45Rlo CD4+ T cells. J Immunol 1990 144 : 3288 3295.
33. Xu Z, Weiss A. Negative regulation of CD45 by differential homodimerisation of the alternatively spliced isoforms. Nat immunol 2002 3 : 764.
34. Irles C, Symons A, Michel F, Bakker TR, Van Der Merwe AP, Acuto O. CD45 ectodomain controls interaction with GEMs and Lck activity for optimal TCR signalling. Nat Immunol 2003 4 : 189 197.
35. + suppressor T cells in vivo. Nat Immunol 2002 3 : 33 41.
36. Game DS, Hernandez-Fuentes MP, Chaudhry AN, Lechler RI. CD4+CD25+ regulatory T cells do not significantly contribute to direct pathway hyporesponsiveness in stable renal transplant patients. J Am Soc Nephrol 2003 14 : 1652 1661.
37. Salama AD, Najafian N, Clarkson MR, Harmon WE, Sayegh MH. Regulatory CD25+ T cells in human kidney transplant recipients. J Am Soc Nephrol 2003 14 : 1643 1651.
38. Sanchez-Fueyo A, Domenig CM, Mariat C, Alexopoulos S, Zheng XX, Strom TB. Influence of direct and indirect allorecognition pathways on CD4+CD25 +regulatory T-cell function in transplantation. Transplant Int 2007 20 : 534 541.
39. Marelli-Berg FM, Hargreaves RE, Carmichael P, Dorling A, Lombardi G, Lechler RI. Major histocompatibility complex class II-expressing endothelial cells induce allospecific nonresponsiveness in naive T cells. J Exp Med 1996 183 : 1603 1612.
40. + T cells. J Immunol 1997 159 : 5853 5861.
41. Baker RJ, Hernandez-Fuentes MP, Brookes PA, Chaudhry AN, Lechler RI. The role of the allograft in the induction of donor-specific T cell hyporesponsiveness. Transplantation 2001 72 : 480 485.
42. Lechler RI, Batchelor JR. Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J Exp Med 1982 155 : 31 41.
43. Baker RJ, Hernandez-Fuentes MP, Brookes PA, Chaudhry AN, Cook HT, Lechler RI. Loss of direct and maintenance of indirect alloresponses in renal allograft recipients: Implications for the pathogenesis of chronic allograft nephropathy. J Immunol 2001 167 : 7199 7206.
44. Hornick PI, Mason PD, Baker RJ et al. Significant frequencies of T cells with indirect anti-donor specificity in heart graft recipients with chronic rejection. Circulation 2000 101 : 2405 2410.
45. Lee RS, Yamada K, Houser SL et al. Indirect recognition of allopeptides promotes the development of cardiac allograft vasculopathy. Proc Natl Acad Sci USA 2001 98 : 3276 3281.
46. Lombardi G, Sidhu S, Daly M, Batchelor JR, Makgoba W, Lechler RI. Are primary alloresponses truly primary Int Immunol 1990 2 : 9 13.
47. Mason D. A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol Today 1998 19 : 395 404.
48. Adams AB, Williams MA, Jones TR et al. Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest 2003 111 : 1887 1895.
49. Wu Z, Bensinger SJ, Zhang J et al. Homeostatic proliferation is a barrier to transplantation tolerance. Nat Med 2004 10 : 87 92.
50. Pearl JP, Parris J, Hale DA et al. Immunocompetent T cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion. Am J Transplant 2005 5 : 465 474.